Work

A Phase 2 Consortium (P2C) Trial of R115777 (Tipifarnib) in Myelofibrosis with Myeloid Metaplasia.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.1509.1509

Authors: Ruben A. Mesa, John K. Camoriano, Susan M. Geyer, Scott H. Kaufmann, Candido E. Rivera, Charles Erlichman, Ayalew Tefferi

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2569690486

FWCI: 1.709

Cites:

Cited by: 14

Related to: 10